Clinical Trials Browser

Active not recruiting × Fallopian Tube Neoplasms × Interleukin-2 × Clear all

NCT01883297 2024-09-05

"Re-Stimulated" TILs and IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 1 Active not recruiting

Fallopian Tube Neoplasms, Recurrence